Triangle Compounding

Form 483 issued April 4, 2019 · Caty, North Carolina

Inspection
Mar 26 – Apr 4, 2019
Investigators
Adam R. Cooke· Seneca Toms
Observations
1
Pages
2
FEI number
3004969894

In short: On April 4, 2019, FDA issued a Form 483 with 1 observation to Triangle Compounding in Caty, North Carolina (FEI 3004969894) after an inspection that ran Mar 26 – Apr 4, 2019. The investigators were Adam R. Cooke and Seneca Toms. Most observations concern materials; the most-cited regulation is 21 CFR 211.94 (drug product containers and closures).

At a glance

1 of 1 observations on this 483 concern materials.

Materials1

Most cited: 21 CFR 211.94 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Drug product has been prepared using a method of manufacture that does not assure it meets…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Triangle Compounding?

FDA listed 1 observation on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.94 (drug product containers and closures). The opening words of each observation are shown on this page.

Who inspected Triangle Compounding?

Adam R. Cooke and Seneca Toms are named on this Form 483, for the inspection of Mar 26 – Apr 4, 2019. Each investigator has a profile showing what they cite most.

When was Triangle Compounding inspected by FDA?

The inspection ran Mar 26 – Apr 4, 2019, and the Form 483 is dated April 4, 2019.

How do I get the full Form 483 for Triangle Compounding?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free